Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • 언어
  • 1833-5784 문의
  • 1833-5784 문의
  • Part of brands: |
KoreaKorea
  • Part of brands: |
  • 예비맘
    • 검사안내
    • ERA 검사
    • EMMA 검사
    • ALICE 검사
    • EndomeTRIO 검사
    • PGS/PGT-A 검사
    • PGT-M 검사
    • CGT 검사
  • 의료인
    • 검사안내
    • ERA 검사
    • EMMA 검사
    • ALICE 검사
    • EndomeTRIO 검사
    • PGS/PGT-A 검사
    • PGT-M 검사
    • CGT 검사
  • 난임 유형별 맞춤검사
  • ERA 검사
  • 유전체 정밀진단
  • ACADEMY
    • Igenomix APAC 웹비나
    • 한국 웹비나
  • 블로그
Home > Genetic Solutions

CGT: Carrier Genetic Test

CGT is an advanced carrier genetic test before pregnancy to determine the risk of having a chind with a genetic disease.

  • Technical overview
  • Disorders
  • Gamete banks
  • Documentation
  • Scientific evidence
  • Tools
  • I’m not a health specialist

The global prevalence of genetic diseases is 10 in 1000 newborn infants.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

84% of individuals are carriers of at least one condition.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

The average person is carrier of 2 disease-causing mutations.

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

Inherited disorders represent 20% of the causes of infant mortality in developed countries

[*] ACOG Committee on Genetics
This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Genetics in collaboration with committee members Britton Rink, MD;
Stephanie Romero, MD; Joseph R. Biggio Jr, MD; Devereux N. Saller Jr, MD; and Rose Giardine, MS.

Request information

We answer in 48 hours lorem ipsum sis amet

Write us

Course CGT

Access the e-learning portal to attend the course

Order now
About CGT

What is a single gene disorder?

A single gene disorder it’s a hereditary disorder caused by the presence of a mutation, or mutations, in a particular gene. Gene disorders can’t be cured, but they can be prevented.

It identifies couples in which both partners are carriers. In this way it prevents serious genetic disorders in their offspring.

It analises disorders such as Cystic Fibrosis, Spinal Muscular Atrophy, Fragile-X Syndrome amongst others by NGS.

If both partners carry a mutation in the same gene, they will be at high risk of having an affected child. In these cases, there are options for conceiving healthy children, like Preimplantation Genetic Diagnosis or gamete donation. It’s also possible to use prenatal diagnosis after conceiving naturally.

Most carriers of genetic mutations don’t have a family history of these disorders

Test features

  • Study on more than 6,000 mutations associated with over 600 genetic disorders.
  • Genetic counseling for patients and specialists.
  • Availability of a specific module for gamete donation programs.
  • Genetic screening test based on massive sequencing (NGS) and clinically validated.

Who is this test for?

For any couple who wants to form a family to know the risk of transmitting hereditary disorders to their children

Before an assisted reproduction treatment

Before a treatment with donor sperm or eggs.

Which disorders are studied?

It analises disorders such as Cystic Fibrosis, Spinal Muscular Atrophy,
Fragile-X Syndrome amongst others.

CGT 600 Related publications

What’s the procedure?

The test requires 5 ml of blood collected in an EDTA tube which is transported at room temperatur and with the recommended protection: a padded envelope or in the pack sent in the kit. The sample should be sent within a maximum of 48 hours.

How is a carrier screening performed?

Doctor prescibes test
Blood sample
DN Aanlaysis by NGS
Mutation report

How do we interpret the results?

+ POSITIVE

If the tested person carries a mutation in a particular gene, the test should be carried out in the other member of the couple.

- NEGATIVE

A negative result indicates that the person doesn’t carry any of the mutations studied. There is still residual risk of carrying another mutation not analyzed by the test.

Application of the test to the donor bank

At Igenomix we offer the test to infertility clinic patients receiving a sperm or egg donation. The joint study of both the donor and recipient significantly reduces the possibility of having a baby affected by the disorders studied.

Why choose the Igenomix Carrier Screening Test?

39,000

TESTS PERFORMED

53

PARTNER CLINICS

14

LABS IN 9 COUNTRIES

How can I explain this service to my patients

Non-technical explanation for your patients Brochure for your patients Product sheet
Documentation & Resources

For printing or to download

브로셔

다운로드

브로셔

다운로드

브로셔

다운로드

Tools:

TOOLS

Calculator

Sociis natoque penatibus et magnis dis parturient montes.

Download
Scientific evidence

Relevant related studies:

Vafai, S. B. & Mootha, V. K.

Mitochondrial disorders as windows into an ancient organelle

Nature 491, 374–383 (2012)

Read
Vafai, S. B. & Mootha, V. K.

Mitochondrial disorders as windows into an ancient organelle

Nature 491, 374–383 (2012)

Read
Methodology
CGT for gamete banks

 Lorem ipsum dolor est

The Carrier Screening Test from Igenomix provides a powerful and exclusive computerized
tool called CGT Match. This software allows genetically matched gametes to be selected for a
recipient after analyzing the egg or sperm bank of an assisted reproduction clinic.

Difference between a genetically tesed banck and a non tested bank

1 / 20

A banck whis is not genetically tested, uses eggs with a hight risk of transmitting a genetic disease

TESTED

1 / 110,000

A banck whis is not genetically tested, uses eggs with a hight risk of transmitting a genetic disease

NON TESTED
Technical information

Test limitations

  • The sensitivity of the test is 98%.
  • We only analyze genes on the list available, reporting results based on knowledge current at the time of testing. Therefore, only genes included in this list will be detected.
  • The method is based on analysis by massive parallel sequencing and bioinformatics, studying all the exons of the genes included on our gene list. This includes adjacent intronic regions before or after position +5 and -5. Variants located outside the gene regions studied, such as gene-expression regulatory regions or intronic regions before or after position +5 and -5 are not detected.
  • No inversions, deletions, or duplications over 20 nucleotides long that are not referred to in the list available, are studied.
  • Germ mosaics (mutations only present in gametes) are not detected by this analysis because the DNA material studied is obtained from a blood sample.
  • A negative result for the genes indicated does not exclude the possibility that a de novo mutation may appear in the offspring.

If you´re a little lost with this technical information...

Can we help you?

I’m not a health specialist

아이지노믹스 소개

아이지노믹스는 생식 유전자 검사 서비스에 특화된 의료 임상 테스트 연구소에서 불임이 더 이상 불가능한 장벽이 아닌 세계의 실현을 위해 노력하고 있습니다. 전세계 의료기관과 임신 전문의들과 함께 우리는 임신을 원하는 부부의 인생을 바꿀 생명 잉태의 성공을 연구하고 있습니다.

Learn more about Igenomix
email

Subscribe to
our newsletter

[gravityform id=1 title=false description=false ajax=true tabindex=49]

Learn about
genetics

Related courses and learning paths

Lorem ipsum sis amet

Sociis natoque penatibus et
magnis dis parturient montes,
nascetur ridiculus mus. Nam
fermentum, nulla luctus pharetra
vulputate, felis tellus mollis orci,
sed rhoncus pronin sapien nunc
accuan eget.

More information

Lorem ipsum sis amet

Sociis natoque penatibus et
magnis dis parturient montes,
nascetur ridiculus mus. Nam
fermentum, nulla luctus pharetra
vulputate, felis tellus mollis orci,
sed rhoncus pronin sapien nunc
accuan eget.

More information

고객 문의 센터

[gravityform id=4 title=false description=false ajax=true tabindex=49]

Igenomix related services

Proain agravida dolor sit amet lacus accumsan et viverra justo commodo

PGS

Preimplantation Genetic Screening

Early risk detection of hereditary breast and ovarian cancer

More information

Block "788" not found

예비맘 사이트

검사안내
고충유형

의료인 사이트

검사안내
과학세미나

기업 정보

아이지노믹스 소개
글로벌 지점
채용 정보

블로그
뉴스

아이지노믹스 코리아

경기도 용인시 수지구 신수로 767, 분당수지 U-Tower A동 3층 316호 (우편번호: 16827)

토~일, 공휴일 휴무,영업 시간 : 9시 ~ 18시

1833-5784
문의

  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
언어

[2024] © Igenomix 개인 정보 보호 정책쿠키 정책

문의


  • reCAPTCHA demo: Simple page

  • 예비맘
    • 검사안내
    • ERA 검사
    • EMMA 검사
    • ALICE 검사
    • EndomeTRIO 검사
    • PGS/PGT-A 검사
    • PGT-M 검사
    • CGT 검사
  • 의료인
    • 검사안내
    • ERA 검사
    • EMMA 검사
    • ALICE 검사
    • EndomeTRIO 검사
    • PGS/PGT-A 검사
    • PGT-M 검사
    • CGT 검사
  • 난임 유형별 맞춤검사
  • ERA 검사
  • 유전체 정밀진단
  • ACADEMY
    • Igenomix APAC 웹비나
    • 한국 웹비나
  • 블로그
  • 언어